| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 3 | 14.8 | 23 | 171.2 | 472.4 | 10.8 | - | - | - | 695.3 |
| - | - | 2 | 8.6 | 123.8 | 223 | 2 | - | - | - | 359.3 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 3.5 |
| 0.5 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 6,201 | 98.6% | -0.94 | 3,228 | 99.1% |
| Optic-unspecified(L) | 78 | 1.2% | -1.43 | 29 | 0.9% |
| AME(L) | 7 | 0.1% | -2.81 | 1 | 0.0% |
| upstream partner | # | NT | conns Cm11d | % In | CV |
|---|---|---|---|---|---|
| Dm8b (L) | 249 | Glu | 181.1 | 27.4% | 0.7 |
| MeVC22 (L) | 2 | Glu | 94.4 | 14.3% | 0.2 |
| Dm2 (L) | 302 | ACh | 56.3 | 8.5% | 0.6 |
| Cm2 (L) | 139 | ACh | 48.9 | 7.4% | 0.7 |
| MeVPMe13 (R) | 1 | ACh | 37.3 | 5.6% | 0.0 |
| Mi15 (L) | 146 | ACh | 36.6 | 5.5% | 0.7 |
| L3 (L) | 52 | ACh | 17.4 | 2.6% | 1.0 |
| Tm5a (L) | 88 | ACh | 16.9 | 2.6% | 0.6 |
| MeVPMe13 (L) | 1 | ACh | 16.3 | 2.5% | 0.0 |
| Cm28 (L) | 6 | Glu | 15.7 | 2.4% | 0.4 |
| R7p | 48 | HA | 10.7 | 1.6% | 0.7 |
| Dm-DRA1 (L) | 20 | Glu | 10.6 | 1.6% | 1.2 |
| MeTu1 (L) | 31 | ACh | 9.9 | 1.5% | 0.7 |
| R7_unclear | 44 | HA | 9.4 | 1.4% | 0.7 |
| Dm-DRA2 (L) | 13 | Glu | 6.9 | 1.0% | 0.5 |
| Cm20 (L) | 12 | GABA | 6.6 | 1.0% | 0.7 |
| Dm8a (L) | 31 | Glu | 5 | 0.8% | 0.7 |
| Tm5b (L) | 32 | ACh | 4.7 | 0.7% | 0.6 |
| Cm17 (L) | 12 | GABA | 4.4 | 0.7% | 0.7 |
| Cm27 (L) | 4 | Glu | 4.3 | 0.7% | 0.7 |
| R7d | 15 | HA | 4.1 | 0.6% | 0.6 |
| Dm9 (L) | 23 | Glu | 4 | 0.6% | 0.6 |
| MeVC20 (L) | 2 | Glu | 3.3 | 0.5% | 0.5 |
| MeVC11 (R) | 1 | ACh | 3.2 | 0.5% | 0.0 |
| aMe17e (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| Cm11a (L) | 16 | ACh | 2.8 | 0.4% | 0.6 |
| Cm21 (L) | 8 | GABA | 2.6 | 0.4% | 0.9 |
| Cm7 (L) | 11 | Glu | 2.3 | 0.4% | 0.5 |
| aMe12 (L) | 4 | ACh | 2.3 | 0.4% | 0.4 |
| R8d | 10 | HA | 2.2 | 0.3% | 0.6 |
| Cm1 (L) | 16 | ACh | 2.1 | 0.3% | 0.3 |
| MeTu3c (L) | 14 | ACh | 2 | 0.3% | 0.6 |
| ME_LO_unclear (L) | 1 | unc | 1.8 | 0.3% | 0.0 |
| Dm11 (L) | 11 | Glu | 1.7 | 0.3% | 0.5 |
| Cm35 (L) | 1 | GABA | 1.6 | 0.2% | 0.0 |
| Cm3 (L) | 12 | GABA | 1.4 | 0.2% | 0.3 |
| MeVP2 (L) | 8 | ACh | 1.3 | 0.2% | 0.6 |
| Cm11c (L) | 7 | ACh | 1.2 | 0.2% | 0.6 |
| TmY20 (L) | 10 | ACh | 1.1 | 0.2% | 0.0 |
| Cm5 (L) | 7 | GABA | 1 | 0.2% | 0.5 |
| R8_unclear | 6 | HA | 0.9 | 0.1% | 0.4 |
| MeVPMe12 (L) | 2 | ACh | 0.9 | 0.1% | 0.5 |
| Tm5c (L) | 7 | Glu | 0.9 | 0.1% | 0.3 |
| Tm12 (L) | 7 | ACh | 0.9 | 0.1% | 0.3 |
| MeTu3b (L) | 7 | ACh | 0.9 | 0.1% | 0.3 |
| Cm11b (L) | 5 | ACh | 0.8 | 0.1% | 0.3 |
| Tm38 (L) | 2 | ACh | 0.7 | 0.1% | 0.7 |
| Cm26 (L) | 5 | Glu | 0.7 | 0.1% | 0.3 |
| MeVPLo2 (L) | 3 | ACh | 0.7 | 0.1% | 0.7 |
| Cm32 (L) | 1 | GABA | 0.6 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 0.6 | 0.1% | 0.0 |
| aMe5 (L) | 3 | ACh | 0.6 | 0.1% | 0.6 |
| Mi9 (L) | 5 | Glu | 0.6 | 0.1% | 0.0 |
| Cm31a (L) | 2 | GABA | 0.6 | 0.1% | 0.2 |
| Mi10 (L) | 5 | ACh | 0.6 | 0.1% | 0.0 |
| MeVC27 (R) | 3 | unc | 0.4 | 0.1% | 0.4 |
| Cm33 (L) | 1 | GABA | 0.4 | 0.1% | 0.0 |
| Tm29 (L) | 4 | Glu | 0.4 | 0.1% | 0.0 |
| LT58 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| Cm19 (L) | 2 | GABA | 0.3 | 0.1% | 0.3 |
| aMe17c (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| aMe26 (L) | 2 | ACh | 0.3 | 0.1% | 0.3 |
| Cm9 (L) | 3 | Glu | 0.3 | 0.1% | 0.0 |
| aMe2 (L) | 2 | Glu | 0.3 | 0.1% | 0.3 |
| R7y | 3 | HA | 0.3 | 0.1% | 0.0 |
| Tm30 (L) | 3 | GABA | 0.3 | 0.1% | 0.0 |
| Tm37 (L) | 3 | Glu | 0.3 | 0.1% | 0.0 |
| Tm5Y (L) | 3 | ACh | 0.3 | 0.1% | 0.0 |
| MeLo4 (L) | 3 | ACh | 0.3 | 0.1% | 0.0 |
| TmY5a (L) | 3 | Glu | 0.3 | 0.1% | 0.0 |
| Cm30 (L) | 2 | GABA | 0.3 | 0.1% | 0.3 |
| Cm4 (L) | 3 | Glu | 0.3 | 0.1% | 0.0 |
| LC14b (R) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MeVP21 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| aMe6c (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| MeVP7 (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 0.2 | 0.0% | 0.0 |
| R8p | 2 | HA | 0.2 | 0.0% | 0.0 |
| ME_unclear (L) | 2 | Glu | 0.2 | 0.0% | 0.0 |
| Cm31b (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| Tm39 (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| TmY10 (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| Cm34 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| aMe17a (L) | 1 | unc | 0.2 | 0.0% | 0.0 |
| MeTu2a (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Cm-DRA (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| aMe4 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Cm22 (L) | 2 | GABA | 0.2 | 0.0% | 0.0 |
| Mi2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Pm4 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Dm12 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP43 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm10 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP14 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP8 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| DNc01 (R) | 1 | unc | 0.1 | 0.0% | 0.0 |
| T2a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP41 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm23 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi4 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm29 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP15 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu2b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe9 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeLo3b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm16 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm40 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm8 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm25 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP9 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| HBeyelet (L) | 1 | HA | 0.1 | 0.0% | 0.0 |
| MeVP6 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm11d | % Out | CV |
|---|---|---|---|---|---|
| Dm8b (L) | 260 | Glu | 811 | 52.1% | 0.5 |
| Dm8a (L) | 264 | Glu | 361.9 | 23.2% | 0.7 |
| Tm5b (L) | 189 | ACh | 97.7 | 6.3% | 0.7 |
| Dm-DRA2 (L) | 15 | Glu | 38.4 | 2.5% | 0.6 |
| Dm-DRA1 (L) | 24 | Glu | 23.8 | 1.5% | 0.8 |
| MeTu1 (L) | 59 | ACh | 18.2 | 1.2% | 1.0 |
| MeVPLo2 (L) | 7 | ACh | 16.4 | 1.1% | 0.8 |
| aMe12 (L) | 4 | ACh | 14.7 | 0.9% | 0.2 |
| Dm11 (L) | 26 | Glu | 11.6 | 0.7% | 2.5 |
| aMe4 (L) | 10 | ACh | 11.6 | 0.7% | 0.5 |
| Cm8 (L) | 37 | GABA | 11.3 | 0.7% | 0.9 |
| MeVP63 (L) | 1 | GABA | 11.1 | 0.7% | 0.0 |
| Cm5 (L) | 37 | GABA | 11 | 0.7% | 0.6 |
| Cm3 (L) | 39 | GABA | 10.1 | 0.6% | 0.6 |
| Cm22 (L) | 8 | GABA | 9 | 0.6% | 0.7 |
| Tm5a (L) | 40 | ACh | 7.7 | 0.5% | 0.5 |
| MeVP9 (L) | 7 | ACh | 7 | 0.4% | 0.5 |
| MeVP41 (L) | 1 | ACh | 6.7 | 0.4% | 0.0 |
| aMe5 (L) | 11 | ACh | 6.4 | 0.4% | 0.7 |
| L3 (L) | 39 | ACh | 5.4 | 0.3% | 0.4 |
| Dm2 (L) | 38 | ACh | 4.9 | 0.3% | 0.3 |
| MeVP43 (L) | 1 | ACh | 3.1 | 0.2% | 0.0 |
| Cm1 (L) | 18 | ACh | 3.1 | 0.2% | 0.5 |
| Tm5c (L) | 17 | Glu | 3 | 0.2% | 0.6 |
| Mi20 (L) | 1 | Glu | 2.7 | 0.2% | 0.0 |
| MeVPMe6 (L) | 1 | Glu | 2.3 | 0.1% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 2.2 | 0.1% | 0.0 |
| Cm4 (L) | 14 | Glu | 2.1 | 0.1% | 0.5 |
| Lawf1 (L) | 13 | ACh | 1.9 | 0.1% | 0.5 |
| MeVPMe13 (R) | 1 | ACh | 1.8 | 0.1% | 0.0 |
| MeVP10 (L) | 8 | ACh | 1.8 | 0.1% | 0.8 |
| Cm10 (L) | 7 | GABA | 1.8 | 0.1% | 0.6 |
| Mi15 (L) | 14 | ACh | 1.8 | 0.1% | 0.3 |
| MeVP2 (L) | 11 | ACh | 1.7 | 0.1% | 0.8 |
| Tm29 (L) | 6 | Glu | 1.6 | 0.1% | 0.9 |
| MeTu3c (L) | 11 | ACh | 1.6 | 0.1% | 0.3 |
| Cm31a (L) | 2 | GABA | 1.4 | 0.1% | 0.2 |
| MeVP8 (L) | 4 | ACh | 1.2 | 0.1% | 0.9 |
| Dm4 (L) | 5 | Glu | 1.1 | 0.1% | 0.8 |
| MeVP15 (L) | 4 | ACh | 1.1 | 0.1% | 0.4 |
| ME_unclear (L) | 2 | Glu | 1 | 0.1% | 0.8 |
| Cm11a (L) | 4 | ACh | 1 | 0.1% | 0.6 |
| Tm37 (L) | 6 | Glu | 1 | 0.1% | 0.5 |
| Cm2 (L) | 5 | ACh | 1 | 0.1% | 0.4 |
| Cm12 (L) | 8 | GABA | 1 | 0.1% | 0.3 |
| Cm9 (L) | 4 | Glu | 0.9 | 0.1% | 0.4 |
| MeVPaMe2 (L) | 1 | Glu | 0.8 | 0.0% | 0.0 |
| MeVC22 (L) | 2 | Glu | 0.8 | 0.0% | 0.1 |
| Dm9 (L) | 7 | Glu | 0.8 | 0.0% | 0.0 |
| MeVP59 (L) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| MeTu3b (L) | 3 | ACh | 0.7 | 0.0% | 0.4 |
| Mi18 (L) | 3 | GABA | 0.7 | 0.0% | 0.7 |
| Cm6 (L) | 5 | GABA | 0.7 | 0.0% | 0.3 |
| Cm11b (L) | 5 | ACh | 0.7 | 0.0% | 0.3 |
| Cm11c (L) | 6 | ACh | 0.7 | 0.0% | 0.0 |
| Tm39 (L) | 3 | ACh | 0.6 | 0.0% | 0.6 |
| Tm12 (L) | 4 | ACh | 0.6 | 0.0% | 0.3 |
| Dm10 (L) | 5 | GABA | 0.6 | 0.0% | 0.0 |
| MeVP25 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| MeVP42 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| Cm20 (L) | 3 | GABA | 0.4 | 0.0% | 0.4 |
| Cm14 (L) | 4 | GABA | 0.4 | 0.0% | 0.0 |
| C2 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Tm20 (L) | 2 | ACh | 0.3 | 0.0% | 0.3 |
| Tm9 (L) | 2 | ACh | 0.3 | 0.0% | 0.3 |
| Cm31b (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Cm18 (L) | 3 | Glu | 0.3 | 0.0% | 0.0 |
| Mi10 (L) | 3 | ACh | 0.3 | 0.0% | 0.0 |
| Tm4 (L) | 3 | ACh | 0.3 | 0.0% | 0.0 |
| Cm19 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| Cm27 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Mi14 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| R7_unclear | 2 | HA | 0.2 | 0.0% | 0.0 |
| Dm12 (L) | 2 | Glu | 0.2 | 0.0% | 0.0 |
| MeVPMe7 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| TmY13 (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| T2 (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| MeTu2a (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| R7p | 2 | HA | 0.2 | 0.0% | 0.0 |
| TmY14 (L) | 2 | unc | 0.2 | 0.0% | 0.0 |
| Cm26 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY18 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm33 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeLo3a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| DNc01 (R) | 1 | unc | 0.1 | 0.0% | 0.0 |
| Tm2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm28 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP55 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| aMe2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm3 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm21 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeLo7 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm23 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP14 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| l-LNv (L) | 1 | unc | 0.1 | 0.0% | 0.0 |
| MeVC9 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY5a (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm5Y (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi4 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Mi9 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm29 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm33 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm40 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Lawf2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu3a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |